Aileron Therapeutics Inc
General ticker "ALRN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $46.4M
Aileron Therapeutics Inc does not follow the US Stock Market performance with the rate: -29.8%.
Estimated limits based on current volatility of 8.2%: low 1.98$, high 2.34$
Short-term ALRN quotes
Long-term ALRN plot
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $26.61MM | $27.65MM | $16.28MM |
| Operating Income | $-26.61MM | $-27.65MM | $-16.28MM |
| Non-Operating Income | $0.44MM | $0.32MM | $0.54MM |
| R&D Expense | $17.01MM | $17.97MM | $3.99MM |
| Income(Loss) | $-26.16MM | $-27.33MM | $-15.73MM |
| Profit(Loss)* | $-25.76MM | $-27.01MM | $-15.73MM |
| Stockholders Equity | $43.90MM | $18.62MM | $6.89MM |
| Assets | $48.48MM | $22.01MM | $106.01MM |
| Operating Cash Flow | $-23.75MM | $-24.86MM | $-19.81MM |
| Capital expenditure | $0.16MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-35.92MM | $26.46MM | $16.20MM |
| Financing Cash Flow | $55.66MM | $0.00MM | $15.79MM |
| Earnings Per Share** | $-5.80 | $-5.95 | $-3.42 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.